Results 11 to 20 of about 466,856 (291)

Glaucoma therapy: preservative-free for all?

open access: yesClinical Ophthalmology, 2018
John Thygesen Department of Ophthalmology, Glaucoma Services in Copenhagen, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Abstract: Preservatives used in topical glaucoma medications have a plethora of well-described toxic effects
Thygesen J
doaj   +1 more source

Alternatives to Topical Glaucoma Medication for Glaucoma Management. [PDF]

open access: yesClin Ophthalmol, 2023
Topical glaucoma medications have favorable safety and efficacy, but their use is limited by factors such as side effects, nonadherence, costs, ocular surface disease, intraocular pressure fluctuations, diminished quality of life, and the inherent difficulty of penetrating the corneal surface. Although traditionally these limitations have been accepted
Bedrood S   +3 more
europepmc   +5 more sources

Patterns and Facilitators for the Promotion of Glaucoma Medication Adherence-A Qualitative Study. [PDF]

open access: yesHealthcare (Basel), 2021
Primary open-angle glaucoma (POAG) is a chronic optic neuropathy causing irreversible nerve fiber damage. Initially asymptomatic, it progresses slowly without any notable sign of vision loss, thus early detection and treatment is essential.
Frech S   +7 more
europepmc   +2 more sources

Glaucoma Medication Preferences among Glaucoma Specialists in Mexico

open access: yesJournal of Current Glaucoma Practice, 2017
Aim To determine the glaucoma specialists' preferences for the different brands of topical glaucoma medications available in Mexico. Materials and methods A web-based survey was sent to 150 board-certified glaucoma specialists in Mexico, with 14 ...
Daniela Alvarez-Ascencio   +10 more
core   +3 more sources

Preservatives in glaucoma medication. [PDF]

open access: yesBr J Ophthalmol, 2018
Preservatives continue to be in widespread use in ophthalmic medications due to the convenience they provide, regulatory requirements and the higher cost of alternatives. Benzalkonium chloride (BAK) remains the most commonly used preservative but there is a trend towards the use of preservative-free (PF) drops for glaucoma, although at a higher price ...
Steven DW, Alaghband P, Lim KS.
europepmc   +6 more sources

The Accuracy of Accredited Glaucoma Optometrists in the Diagnosis and Treatment Recommendation for Glaucoma [PDF]

open access: yes, 2007
Background/aims: To compare the diagnostic performance of accredited glaucoma optometrists (AGO) for both the diagnosis of, and decision to treat glaucoma with that of routine hospital eye care against a reference standard of expert opinion, i.e ...
Burr, J.   +13 more
core   +3 more sources

Reasons for choice of glaucoma surgery in eyes not treated with anti-glaucoma medications

open access: yesBMC Ophthalmology, 2022
Background In the real world, some glaucoma patients can undergo an incisional glaucoma surgery without using medication. The rate of cases with no medication treatment at the time of surgery among those that underwent incisional glaucoma surgeries ...
Kazunobu Sugihara   +3 more
doaj   +1 more source

Improved Glaucoma Medication Adherence in a Randomized Controlled Trial.

open access: yes, 2022
PurposeTo test the effectiveness of an intervention designed to improve glaucoma medication adherence.DesignRandomized, controlled trial at a Veterans Affairs (VA) eye clinic.ParticipantsVeterans with medically treated glaucoma who reported poor ...
Hein, Aaron M   +15 more
core   +1 more source

Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma. [PDF]

open access: yes, 2012
20.02.14 KB. Ok to add published verson to spiral, OA paper.A pilot study to determine whether topical prostaglandin analogues alter the expression of conjunctival inflammatory markers in patients with uveitic glaucoma.Prospective, single-masked case ...
Sallam, A   +3 more
core   +1 more source

Which quality of life score is best for glaucoma patients and why? [PDF]

open access: yes, 2008
Background: the glaucomas are generally asymptomatic diseases until they are very advanced. They affect 2% of the population over 40 years of age and therefore represent a significant public health issue.
May, Carl   +15 more
core   +2 more sources

Home - About - Disclaimer - Privacy